PTC Therapeutics, Inc.: net_income
| Value | {"amount": -626600000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2023-01-01 – 2023-12-31 |
| Status | current |
| Entity | PTC Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T10:36:09.179410+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/84845c9c-38d0-492a-bd53-191a0dab44dd
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001104659-26-045528Retrieved: 2026-08-19T10:36:09.179410+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001070081/net-income/2023-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/84845c9c-38d0-492a-bd53-191a0dab44dd
History
- supersedes {"amount": -626604000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} (evidence 0001558370-24-002196)